Tuna Semerci, Alperen İhtiyar, Fatma Demet Arslan, Mehmet Hicri Köseoğlu
Aim: In this study, it was aimed to examine the changes of activated partial thromboplastin time (APTT), prothrombin time (PT), and plasma fibrinogen during the day, which are the most used coagulation tests in daily routine.
Material and Methods: Blood...
Journal of Turkish Clinical Biochemistry
•
2023-04-01
•
DOI: 10.56615/tkbd.2023.06
Emin Savaş Kılavuz, Cihan Kırbaş, Eray Ulu, Nermin Erol
Objective: In this study, we aimed to show whether conditions which cause positive results in 50 gr gestational diabetes screening test also increase the levels of inflammatory markers in pregnant women.
Materials and Methods: Fasting fibrinogen and...
Journal of Turkish Clinical Biochemistry
•
2007-12-01
Banu Arslan Şentürk, Ruhan Uzun, Füsun Üstüner, Mustafa Cirit, Sadık İnce
Objective: Hyperphosphatemia and high calcium X phosphate product are significant and common risk factors of cardiovascular disease in patients with chronic kidney disease. However, the relationship is not clear between increased risk and hyperphosphatemia and elevated calcium...
Journal of Turkish Clinical Biochemistry
•
2006-04-01
Belgin Şenol, Ceyda Kabaroğlu, Saliha Aksun, Sara Habif, Işıl Mutaf, Nevbahar Turgan, Dilek Özmen, Hakan Kültürsay
Purpose: In the recent years, the relationship between inflammation and atherosclerosis induced, which is a chronic inflammatory disease, acute coronary syndromes, including unstable angina and acute myocard infarction, has gained importance. Acute phase reactants, as...
Journal of Turkish Clinical Biochemistry
•
2003-12-01
Emin Savaş Kılavuz, Mehmet Tosun, Tuba Şanlı, Nermin Erol
Objective: The aim of this study is to research relations between first hour glucose and insuline level and inflamation markers in individuals who was loaded 75 grams glucose.
Materials and Methods: 11 individuals who were non obese and normal glucose...
Journal of Turkish Clinical Biochemistry
•
2011-04-01
Hamza Malik Okuyan, Serdar Doğan, Tayibe Bal, Mehmet Çabalak
Aim: The COVID outbreak is a serious health problem affecting socio-economic life and healthcare systems worldwide. Although the role of Semaphorins in some diseases is relatively known, the association of these molecules with the pathogenesis of COVID-19 remains unclear....
Journal of Turkish Clinical Biochemistry
•
2023-08-01
•
DOI: 10.56615/tkbd.2023.10
Erkan Söğüt, Enver Avcı, Füsun Üstüner, Erdinç Arıkan
Objective: Various algorithms for predicting coronary atherosclerosis have been established, most of which are based on large epidemiologic and cohort studies. We examined the predictive value of various clinical and biochem ical markers for angiographically defined coronary...
Journal of Turkish Clinical Biochemistry
•
2006-04-01
Giray Bozkaya, Sibel Bilgili
Introduction: The disease caused by SARS-CoV-2, which the World Health Organization has
considered as a pandemic, was named COVID-19 and has since spread worldwide. The COVID-19
pandemic has drastically changed the way we live and work. During events like COVID-19, it is...
Journal of Turkish Clinical Biochemistry
•
2022-04-01
•
DOI: 10.56615/tkbd.2022.02
Seçkin Özgür Tekeli, Güzin Aykal, Feyza Yağmur Tekeli, Nur Benil Yabacı
Aim: This study aimed to evaluate the performance characteristics of preliminary coagulation tests on the Sysmex CS-5100 coagulation autoanalyzer and compare it with the ACL Top 700 autoanalyzer. Both analyzers were assessed for their ability to measure prothrombin time (PT),...
Journal of Turkish Clinical Biochemistry
•
2025-12-01
•
DOI: 10.56615/tkbd.2025.14
Kaan Kuzu, Giray Bozkaya
Aim: Hereditary thrombophilia is a condition where there is an increased tendency for clot formation due to a genetic variation in the coagulation system. Genetic testing in cases with a preliminary diagnosis of thrombophilia is necessary to confirm the diagnosis, eliminate...
Journal of Turkish Clinical Biochemistry
•
2024-08-01
•
DOI: 10.56615/tkbd.2024.07
B.A. Şentürk, F. Üstüner, S. Aksu, Z. Sülek
Objective: Plasminogen activator inhibitor type I (PAI-1) an inhibitor of fibrinolysis and an important and independent cardiovascular risk factor, has been shown to be elevated in obesity. The aim of this study was to evaluate plasma PAI-1 levels in obese subjects and to...
Journal of Turkish Clinical Biochemistry
•
2005-12-01
Tevfik Noyan
D-dimer antigen is a fibrin degradation product that is formed by the sequential action of three different enzymes on cross-linked fibrin. As such, increased levels of plasma D-dimer should be reliable indicator of thrombus formation. The D-dimer antigen is a specific marker of fibrin clot...
Journal of Turkish Clinical Biochemistry
•
2012-04-01